367 related articles for article (PubMed ID: 20692254)
21. NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice.
Zhou R; Wei H; Sun R; Zhang J; Tian Z
Proc Natl Acad Sci U S A; 2007 May; 104(18):7512-5. PubMed ID: 17463084
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells.
Yang X; Coriolan D; Schultz K; Golenbock DT; Beasley D
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2308-14. PubMed ID: 16179594
[TBL] [Abstract][Full Text] [Related]
23. Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis.
Wörnle M; Schmid H; Banas B; Merkle M; Henger A; Roeder M; Blattner S; Bock E; Kretzler M; Gröne HJ; Schlöndorff D
Am J Pathol; 2006 Feb; 168(2):370-85. PubMed ID: 16436653
[TBL] [Abstract][Full Text] [Related]
24. TLR3 ligand polyinosinic:polycytidylic acid induces IL-17A and IL-21 synthesis in human Th cells.
Holm CK; Petersen CC; Hvid M; Petersen L; Paludan SR; Deleuran B; Hokland M
J Immunol; 2009 Oct; 183(7):4422-31. PubMed ID: 19748983
[TBL] [Abstract][Full Text] [Related]
25. Clusterin regulates vascular smooth muscle cell nodule formation and migration.
Millis AJ; Luciani M; McCue HM; Rosenberg ME; Moulson CL
J Cell Physiol; 2001 Feb; 186(2):210-9. PubMed ID: 11169458
[TBL] [Abstract][Full Text] [Related]
26. SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production.
An H; Zhao W; Hou J; Zhang Y; Xie Y; Zheng Y; Xu H; Qian C; Zhou J; Yu Y; Liu S; Feng G; Cao X
Immunity; 2006 Dec; 25(6):919-28. PubMed ID: 17157040
[TBL] [Abstract][Full Text] [Related]
27. Impaired wound healing with defective expression of chemokines and recruitment of myeloid cells in TLR3-deficient mice.
Lin Q; Fang D; Fang J; Ren X; Yang X; Wen F; Su SB
J Immunol; 2011 Mar; 186(6):3710-7. PubMed ID: 21317384
[TBL] [Abstract][Full Text] [Related]
28. Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma.
Erridge C; Burdess A; Jackson AJ; Murray C; Riggio M; Lappin D; Milligan S; Spickett CM; Webb DJ
Eur J Clin Invest; 2008 Oct; 38(10):713-20. PubMed ID: 18837796
[TBL] [Abstract][Full Text] [Related]
29. Poly I:C-induced activation of NK cells by CD8 alpha+ dendritic cells via the IPS-1 and TRIF-dependent pathways.
Miyake T; Kumagai Y; Kato H; Guo Z; Matsushita K; Satoh T; Kawagoe T; Kumar H; Jang MH; Kawai T; Tani T; Takeuchi O; Akira S
J Immunol; 2009 Aug; 183(4):2522-8. PubMed ID: 19635904
[TBL] [Abstract][Full Text] [Related]
30. Nuclear clusterin accumulation during heat shock response: implications for cell survival and thermo-tolerance induction in immortalized and prostate cancer cells.
Caccamo AE; Desenzani S; Belloni L; Borghetti AF; Bettuzzi S
J Cell Physiol; 2006 Apr; 207(1):208-19. PubMed ID: 16331665
[TBL] [Abstract][Full Text] [Related]
31. Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells.
Matsukura S; Kokubu F; Kurokawa M; Kawaguchi M; Ieki K; Kuga H; Odaka M; Suzuki S; Watanabe S; Takeuchi H; Kasama T; Adachi M
Clin Exp Allergy; 2006 Aug; 36(8):1049-62. PubMed ID: 16911361
[TBL] [Abstract][Full Text] [Related]
32. Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells.
Weber A; Kirejczyk Z; Besch R; Potthoff S; Leverkus M; Häcker G
Cell Death Differ; 2010 Jun; 17(6):942-51. PubMed ID: 20019748
[TBL] [Abstract][Full Text] [Related]
33. TBK1-targeted suppression of TRIF-dependent signaling pathway of toll-like receptor 3 by auranofin.
Park SJ; Lee AN; Youn HS
Arch Pharm Res; 2010 Jun; 33(6):939-45. PubMed ID: 20607500
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis.
Sahar S; Dwarakanath RS; Reddy MA; Lanting L; Todorov I; Natarajan R
Circ Res; 2005 May; 96(10):1064-71. PubMed ID: 15860756
[TBL] [Abstract][Full Text] [Related]
35. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
Oshiumi H; Matsumoto M; Funami K; Akazawa T; Seya T
Nat Immunol; 2003 Feb; 4(2):161-7. PubMed ID: 12539043
[TBL] [Abstract][Full Text] [Related]
36. Overexpressing autoimmune regulator regulates the expression of toll-like receptors by interacting with their promoters in RAW264.7 cells.
Zhu W; Yang W; He Z; Liao X; Wu J; Sun J; Yang Y; Li Y
Cell Immunol; 2011; 270(2):156-63. PubMed ID: 21628060
[TBL] [Abstract][Full Text] [Related]
37. Toll/IL-1 domain-containing adaptor inducing IFN-β (TRIF) mediates innate immune responses in murine peritoneal mesothelial cells through TLR3 and TLR4 stimulation.
Hwang EH; Kim TH; Oh SM; Lee KB; Yang SJ; Park JH
Cytokine; 2016 Jan; 77():127-34. PubMed ID: 26579632
[TBL] [Abstract][Full Text] [Related]
38. TNF receptor-associated factor-1 (TRAF1) negatively regulates Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling.
Su X; Li S; Meng M; Qian W; Xie W; Chen D; Zhai Z; Shu HB
Eur J Immunol; 2006 Jan; 36(1):199-206. PubMed ID: 16323247
[TBL] [Abstract][Full Text] [Related]
39. Scaffolding adaptor protein Gab1 is required for TLR3/4- and RIG-I-mediated production of proinflammatory cytokines and type I IFN in macrophages.
Zheng Y; An H; Yao M; Hou J; Yu Y; Feng G; Cao X
J Immunol; 2010 Jun; 184(11):6447-56. PubMed ID: 20435932
[TBL] [Abstract][Full Text] [Related]
40. Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils.
Cassatella MA; Mosna F; Micheletti A; Lisi V; Tamassia N; Cont C; Calzetti F; Pelletier M; Pizzolo G; Krampera M
Stem Cells; 2011 Jun; 29(6):1001-11. PubMed ID: 21563279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
